Cellular and molecular mechanisms of asthma and COPD
- PMID: 28659395
- DOI: 10.1042/CS20160487
Cellular and molecular mechanisms of asthma and COPD
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) both cause airway obstruction and are associated with chronic inflammation of the airways. However, the nature and sites of the inflammation differ between these diseases, resulting in different pathology, clinical manifestations and response to therapy. In this review, the inflammatory and cellular mechanisms of asthma and COPD are compared and the differences in inflammatory cells and profile of inflammatory mediators are highlighted. These differences account for the differences in clinical manifestations of asthma and COPD and their response to therapy. Although asthma and COPD are usually distinct, there are some patients who show an overlap of features, which may be explained by the coincidence of two common diseases or distinct phenotypes of each disease. It is important to better understand the underlying cellular and molecular mechanisms of asthma and COPD in order to develop new treatments in areas of unmet need, such as severe asthma, curative therapy for asthma and effective anti-inflammatory treatments for COPD.
Keywords: cytokines/2; inflammation; inflammatory cells.
© 2017 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.
Similar articles
-
The role of the NLRP3 inflammasome in the pathogenesis of airway disease.Pharmacol Ther. 2011 Jun;130(3):364-70. doi: 10.1016/j.pharmthera.2011.03.007. Epub 2011 Mar 21. Pharmacol Ther. 2011. PMID: 21421008 Review.
-
Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.J Allergy Clin Immunol. 2003 Nov;112(5):819-27; quiz 828. doi: 10.1016/S0091. J Allergy Clin Immunol. 2003. PMID: 14610463 Review.
-
Airway inflammation and cellular stress in noneosinophilic atopic asthma.Chest. 2006 May;129(5):1194-202. doi: 10.1378/chest.129.5.1194. Chest. 2006. PMID: 16685009
-
Remodeling in asthma and COPD--differences and similarities.Clin Respir J. 2010 May;4 Suppl 1:20-7. doi: 10.1111/j.1752-699X.2010.00193.x. Clin Respir J. 2010. PMID: 20500606 Review.
-
Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.J Physiol Pharmacol. 2008 Dec;59 Suppl 6:271-83. J Physiol Pharmacol. 2008. PMID: 19218651
Cited by
-
Factors associated with COVID-19 among hospitalized patients with severe acute respiratory infections in Serbia, 2022-2023: A test negative case-control study.PLoS One. 2024 Mar 18;19(3):e0299210. doi: 10.1371/journal.pone.0299210. eCollection 2024. PLoS One. 2024. PMID: 38498428 Free PMC article.
-
The role of mitochondria in eosinophil function: implications for severe asthma pathogenesis.Front Cell Dev Biol. 2024 Mar 1;12:1360079. doi: 10.3389/fcell.2024.1360079. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38495619 Free PMC article. Review.
-
Association of dietary flavonoid intakes with prevalence of chronic respiratory diseases in adults.J Transl Med. 2024 Feb 26;22(1):205. doi: 10.1186/s12967-024-04949-7. J Transl Med. 2024. PMID: 38409037 Free PMC article.
-
Monocyte-derived alveolar macrophages are key drivers of smoke-induced lung inflammation and tissue remodeling.Front Immunol. 2024 Jan 29;15:1325090. doi: 10.3389/fimmu.2024.1325090. eCollection 2024. Front Immunol. 2024. PMID: 38348034 Free PMC article.
-
Atmospheric pollen concentrations and chronic obstructive pulmonary disease (COPD) patients visits in Beijing: time series analysis using a generalized additive model.Sci Rep. 2024 Feb 12;14(1):3462. doi: 10.1038/s41598-024-54055-3. Sci Rep. 2024. PMID: 38342942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
